{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":1,"sponsored":0,"items":[{"id":"n_eenxcqjrp27ui3hovsfa","seq":477081,"kind":"article","title":"FDA approves Olumiant for teens with severe alopecia","url":"https://www.healio.com/news/dermatology/20260928/fda-approves-olumiant-for-teens-with-severe-alopecia","summary":"The FDA approved an expanded indication for baricitinib, a once daily oral JAK inhibitor, for teens aged 12 and older with severe alopecia areata, according to an industry press release. The approval marks the second JAK inhibitor treatment for adolescents with severe alopecia areata, which can be more severe and extensive with early onset. “Today’s approval marks an important milestone for young people living with severe alopecia areata and their families, who have had…","published":"2026-09-28T15:42:25Z","seen":"2026-09-28T16:54:30Z","lang":"en","source":{"id":"kite-healio-com-23151b","name":"healio.com","domain":"healio.com"},"via":"kite-healio-com-23151b","topics":["medicine"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q2697787","name":"alopecia","type":"other"}],"mentions":2,"story":"st_ypvaxu6tdn33oisujf3q","category":"health","category_p":0.37,"sentiment":"positive","tone":0.27,"political":0.05}]}